We and our affiliates and vendors use cookies and similar technologies to operate our sites, recognize visitors to our sites, provide secure log-in, collect statistics to optimize site functionality, and deliver content tailored to your interests. Click Accept All to accept all cookies and go directly to the site, click Reject All to reject all but cookies strictly necessary to the functioning of this site (required cookies), or click on Manage Settings to see detailed descriptions of the types of cookies and choose whether to accept certain cookies while on the site.
Order Status
visit thermofisher.com
ABO Blood Subgrouping and Implications in Transplantation
Presenter: William Lane, MD, PhD | Medical Director of the Tissue Typing Lab at Brigham & Women's Hospital and Assistant Professor of Pathology at Harvard Medical School
Are you aware of the implications of ABO subgroups in transplantation?
Dr. William Lane helps you understand ABO genotyping, how it enables ABO minor incompatible (ABOi) transplants and the technologies and resources that are available to help labs perform ABOi transplants.
Topics discussed:
- ABO subgroups and their implications in transplantation
- How ABOi transplants can help patients
- Problem samples and helpful information attained from genotyping
- Review of ABO genotyping technologies
- OPTN's support for ABOi transplants and revised Kidney Allocation System (KAS)
© 2025 Thermo Fisher Scientific Inc. All rights reserved.